Amberger, D.C.; Fischer, Z.; Deen, D.; Hirn-Lopez, A.; Plett, C.; Rabe, A.; Schwepcke, C.; Ugur, S.; Klauer, L.K.; Ansprenger, C.;
et al. Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS. Cancers 2026, 18, 847.
https://doi.org/10.3390/cancers18050847
AMA Style
Amberger DC, Fischer Z, Deen D, Hirn-Lopez A, Plett C, Rabe A, Schwepcke C, Ugur S, Klauer LK, Ansprenger C,
et al. Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS. Cancers. 2026; 18(5):847.
https://doi.org/10.3390/cancers18050847
Chicago/Turabian Style
Amberger, Daniel Christoph, Zuzana Fischer, Diana Deen, Anika Hirn-Lopez, Caroline Plett, Alexander Rabe, Christoph Schwepcke, Selda Ugur, Lara Kristina Klauer, Christian Ansprenger,
and et al. 2026. "Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS" Cancers 18, no. 5: 847.
https://doi.org/10.3390/cancers18050847
APA Style
Amberger, D. C., Fischer, Z., Deen, D., Hirn-Lopez, A., Plett, C., Rabe, A., Schwepcke, C., Ugur, S., Klauer, L. K., Ansprenger, C., Liepert, A., Freudenreich, M., Schmid, C., & Schmetzer, H. M.
(2026). Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS. Cancers, 18(5), 847.
https://doi.org/10.3390/cancers18050847